ERES SEC-arkivering - Abacus Life Inc - Class A- Årsrapport, fuldmagtserklæring, prospekt

Grundlæggende statistik

CIK

1814287

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Abacus Life Inc - Class A

SEC Filings (Chronological Order)

Denne side giver en komplet, kronologisk liste over SEC-arkiveringer, eksklusive ejerskabsregistreringer, som vi leverer andre steder.

May 27, 2026	EX-99.1	Abacus Global Management and Manning & Napier Enter into Strategic Alliance Agreement and Announce Closing of Minority Investment Abacus Global Management and Manning & Napier Enter into Strategic Alliance Agreement and Announce Closing of Minority Investment -Strategic Partnership Brings Longevity Data, Actuarial Expertise, and Expanded Investment Capabilities to Manning & Napier Clients -Minority equity investment of ~$53 million from Abacus in Manning & Napier accelerates Abacus Wealth Advisors Platform with ~$18 Billion AUM Abacus Global Management, Inc.
May 27, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2026 Abacus Globa UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2026 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-
May 11, 2026	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39403 Abacus Glo
May 7, 2026	EX-99.1	ABACUS GLOBAL MANAGEMENT, INC. REPORTS FIRST QUARTER 2026 RESULTS ~ Raises Full-Year 2026 Adjusted Net Income1 Guidance to $100–$106 Million, Up to 24% Increase Year-Over-Year; Issues Q2 Adjusted Net Income Guidance of $24–$26 Million ~ ~ Issues Full ABACUS GLOBAL MANAGEMENT, INC. REPORTS FIRST QUARTER 2026 RESULTS ~ Raises Full-Year 2026 Adjusted Net Income1 Guidance to $100–$106 Million, Up to 24% Increase Year-Over-Year; Issues Q2 Adjusted Net Income Guidance of $24–$26 Million ~ ~ Issues Full-Year 2026 Adjusted EPS1 Guidance of $1.00–$1.05; Q2 Adjusted EPS Guidance of $0.24–$0.26 ~ ~ Generates $91.7 Million in Operating Cash Flow, an Incre
May 7, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2026 Abacus Global UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2026 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-3
April 29, 2026	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confi
April 21, 2026	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confi
April 21, 2026	EX-99.1	ABACUS GLOBAL MANAGEMENT ANNOUNCES KEY LEADERSHIP APPOINTMENTS ABACUS GLOBAL MANAGEMENT ANNOUNCES KEY LEADERSHIP APPOINTMENTS ORLANDO, Fla. – April 21, 2026 – Abacus Global Management, Inc. (“Abacus” or the “Company”) (NYSE: ABX), a leader in the alternative asset management industry, today announced several key leadership appointments effective April 17, 2026, reflecting the continued growth and organizational development of the Company. Alexei Solomon, CPA,
April 21, 2026	ARS	ARS Abacus Global Management, Inc. \| 2026 Shareholder Letter Abacus Global Management, Inc. \| 2026 Shareholder Letter Dear Fellow Shareholders, As we reflect on an exceptional year, we are proud to share the milestones that have defined Abacus Global Management’s continued growth and transformation throughout 2025. Record Financial Performance 2025 was a defining year—the numbers reflect the strength
April 21, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2026 Abacus Glo UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2026 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 00
March 18, 2026	EX-16.1	March 18, 2026 March 18, 2026 U.S. Securities and Exchange Commission Office of the Chief Accountant 100 F Street, NE Washington, DC 20549 Re: Abacus Global Management, Inc. File No. 001-39403 Dear Sir or Madam: We have read Item 4.01 of Form 8-K of Abacus Global Management, Inc. dated March 18, 2026, and agree with the statements concerning our Firm contained therein. Very truly yours, /s/ GRANT THORNTON LLP
March 18, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2026 Abacus Glo UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2026 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 00
March 13, 2026	EX-4.9	ABACUS GLOBAL MANAGEMENT, INC. DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED ABACUS GLOBAL MANAGEMENT, INC. DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED The following is a description of the common stock and 9.875% Fixed Rate Senior Notes due 2028 of Abacus Global Management, Inc. (the “Company,” “we,” “our,” or “us”), which are the only securities of the Company registered pursuant to Section 12 of the Secu
March 13, 2026	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39403 Abacus G
March 13, 2026	EX-21.1	Abacus Global Management, Inc. Subsidiaries of Registrant Abacus Global Management, Inc. Subsidiaries of Registrant The following is a list of Abacus Global Management, Inc. subsidiaries, excluding insignificant subsidiaries in the aggregate. Subsidiaries State or Other Jurisdiction of Incorporation or Organization Longevity Market Assets, LLC Entity also does business under the name: •ABL Tech •ABL Technologies Delaware Abacus Settlements, LLC Entity al
March 12, 2026	EX-99.2	ABACUS GLOBAL MANAGEMENT ANNOUNCES EXECUTION OF DEFINITIVE AGREEMENT TO ACQUIRE A STRATEGIC MINORITY INVESTMENT IN MANNING & NAPIER ~ Will Accelerate Abacus Wealth Advisors Platform, Unlock New Distribution Channels, and Support Joint Product Develop ABACUS GLOBAL MANAGEMENT ANNOUNCES EXECUTION OF DEFINITIVE AGREEMENT TO ACQUIRE A STRATEGIC MINORITY INVESTMENT IN MANNING & NAPIER ~ Will Accelerate Abacus Wealth Advisors Platform, Unlock New Distribution Channels, and Support Joint Product Development ~ ~ Will Gain Strategic Partnership with Manning & Napier’s Wealth and Investment Management Platform Totaling $18 Billion in AUM~ ~ Investment Supported by Fee-Related Earnings ~ ORLANDO, Fla.
March 12, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2026 Abacus Glo UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2026 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 00
March 12, 2026	EX-99.1	ABACUS GLOBAL MANAGEMENT REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS ~ Company Delivers Another Record Quarter, Beating Average Consensus by 20% ~ ~ Marks 11 Consecutive Quarters of Strong Earnings Growth ~ ~ Fourth Quarter and Full Year 2025 R ABACUS GLOBAL MANAGEMENT REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS ~ Company Delivers Another Record Quarter, Beating Average Consensus by 20% ~ ~ Marks 11 Consecutive Quarters of Strong Earnings Growth ~ ~ Fourth Quarter and Full Year 2025 Revenue Up Over 100% Year-Over-Year ~ ~ Full Year 2025 GAAP Net Income of $36.
January 30, 2026	EX-99.1	Abacus Global Management Announces $20 Million Share Repurchase Program ~ Underscores the Board of Directors Confidence in the Company’s Long‑Term Business Model, Recurring Earnings, and Capital Strength ~ Abacus Global Management Announces $20 Million Share Repurchase Program ~ Underscores the Board of Directors Confidence in the Company’s Long‑Term Business Model, Recurring Earnings, and Capital Strength ~ ORLANDO, FL – Jan.
January 30, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2026 Abacus G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2026 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization)
January 9, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2026 Abacus Gl UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2026 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 0
January 9, 2026	EX-99.1	Abacus Global Management Chairman and CEO Jay Jackson Releases Shareholder Letter January 8, 2026 1:00 PM EST ~Company Set to Deliver Record 2025, Continues Recurring Revenue Transition~ ~Reiterates Full-Year Adjusted Net Income Guidance to $80–$84 M ex991abxpressreleasex01 Abacus Global Management Chairman and CEO Jay Jackson Releases Shareholder Letter January 8, 2026 1:00 PM EST ~Company Set to Deliver Record 2025, Continues Recurring Revenue Transition~ ~Reiterates Full-Year Adjusted Net Income Guidance to $80–$84 Million~ ~Completes $50 Million Investment Grade Securitized Product Offering Backed by Life Insurance Assets~ ~Gears Up for New Investment Strategy Launch~ ~Debuts on NYSE Under Symbol ABX~ ORLANDO, Fla.
December 29, 2025	EX-4.1	ABACUS GLOBAL MANAGEMENT, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE COMMON STOCK SPECIMEN COMMON STOCK CERTIFICATE NUMBER NUMBER C- SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP 00258Y 104 ABACUS GLOBAL MANAGEMENT, INC.
December 29, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2025 Abacus UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization)
December 29, 2025	25	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-39403 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-39403 Abacus Global Management, Inc. THE NASDAQ STOCK MARKET LLC (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or register
December 29, 2025	8-A12B/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A/A (Amendment No. 1) FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Abacus Global Management, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A/A (Amendment No. 1) FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware 85-1210472 (State or other jurisdiction of incorporation or organization) (I.R.S
December 29, 2025	8-A12B/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A/A (Amendment No. 2) FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Abacus Global Management, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A/A (Amendment No. 2) FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware 85-1210472 (State or other jurisdiction of incorporation or organization) (I.R.S
December 23, 2025	CERT	NYSE CERTIFICATION New York Stock Exchange 11 Wall Street New York, NY 10005 Tel: +1 212.656.3000 nyse.com December 23, 2025 Chief, Information Technology Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE MS 3040 Washington, DC 20549 To whom it may concern: The New York Stock Exchange certifies its approval for listing and registration of the following securities of Abacus Global Mana
December 23, 2025	8-A12B	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Abacus Global Management, Inc. (Exact name of UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware 85-1210472 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identific
December 22, 2025	424B3	9,302,765 Shares of Common Stock $64,380,575 Aggregate Principal Amount of 9.875% Fixed Rate Senior Notes due 2028 TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(3) Registration No. 333-291789 9,302,765 Shares of Common Stock $64,380,575 Aggregate Principal Amount of 9.875% Fixed Rate Senior Notes due 2028 This prospectus relates to the resale or other disposition from time to time of up to (i) 9,302,765 shares (the “Shares”) of common stock, par value $0.0001 per share (the “Common Stock”) and (ii) $64,380
December 19, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2025 Abacus UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization)
December 19, 2025	EX-99.1	Abacus Global Management Announces Transfer of Listing of its [Class A] Common Stock to the New York Stock Exchange with New Ticker Symbol “ABX” Abacus Global Management Announces Transfer of Listing of its [Class A] Common Stock to the New York Stock Exchange with New Ticker Symbol “ABX” ORLANDO, FL – 12/19/2025 – Abacus Global Management, Inc.
December 18, 2025	EX-FILING FEES	Calculation of Filing Fee Tables FORM S-3 (Form Type) ABACUS GLOBAL MANAGEMENT, INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Exhibit 107 Calculation of Filing Fee Tables FORM S-3 (Form Type) ABACUS GLOBAL MANAGEMENT, INC.
December 18, 2025	CORRESP	Abacus Global Management, Inc. 2101 Park Center Drive, Suite 200 Orlando, Florida 32835 December 18, 2025 Abacus Global Management, Inc. 2101 Park Center Drive, Suite 200 Orlando, Florida 32835 December 18, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Attention: Ms. Madeline Mateo Re: Abacus Global Management, Inc. Registration Statement on Form S-3 File No. 333-291789 Ladies and Gentlemen: In accordance
December 18, 2025	S-3/A	As filed with the Securities and Exchange Commission on December 18, 2025 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on December 18, 2025 Registration No.
November 25, 2025	EX-99.1	Abacus Global Management Announces Timing of Inaugural Dividend Distribution ~ Dividend Distribution Advances Shareholder-Focused Capital Program ~ Abacus Global Management Announces Timing of Inaugural Dividend Distribution ~ Dividend Distribution Advances Shareholder-Focused Capital Program ~ ORLANDO, FL – November 25, 2025 – Abacus Global Management, Inc.
November 25, 2025	EX-25.1	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE Check if an Application to Determine Eligibility of a Trustee Pursuant to Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) ☐ U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 91-1821036 I.R.S. E
November 25, 2025	EX-4.7	Article 1 TERMS OF THE NOTES Exhibit 4.7 THIRD SUPPLEMENTAL INDENTURE (this “Third Supplemental Indenture”), dated as of July 18, 2025, between Abacus Global Management, Inc. (“Abacus” or the “Company”), and U.S. Bank Trust Company, N.A., as trustee under the Indenture referred to below (the “Trustee”). Except as otherwise set forth herein, all capitalized terms shall have the meanings ascribed to such terms in the Indenture.
November 25, 2025	EX-FILING FEES	Calculation of Filing Fee Tables FORM S-3 (Form Type) ABACUS GLOBAL MANAGEMENT, INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Exhibit 107 Calculation of Filing Fee Tables FORM S-3 (Form Type) ABACUS GLOBAL MANAGEMENT, INC.
November 25, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 25, 2025 Abacus UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 25, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization)
November 25, 2025	S-3	As filed with the Securities and Exchange Commission on November 25, 2025 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on November 25, 2025 Registration No.
November 7, 2025	EX-99.1	~ Board of Directors Has Approved an Annual Cash Dividend of $0.20 Per Share ~ Abacus Global Management Enhances Shareholder Returns with Annual Dividend and $10 Million Share Repurchase Program November 6, 2025 9:07 PM EST ~ Board of Directors Has Approved an Annual Cash Dividend of $0.
November 7, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2025 Abacus G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization)
November 7, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe
November 6, 2025	EX-99.1	ABACUS GLOBAL MANAGEMENT REPORTS THIRD QUARTER 2025 RESULTS ~ Company Delivers 10th Consecutive Quarter of Strong Earnings Growth ~ ~ Record Revenue Growth of $63.0 Million, Up 124% Y/Y ~ ~ GAAP Net Income of $7.1 Million ~ ~ Adjusted Net Income Up 6 ABACUS GLOBAL MANAGEMENT REPORTS THIRD QUARTER 2025 RESULTS ~ Company Delivers 10th Consecutive Quarter of Strong Earnings Growth ~ ~ Record Revenue Growth of $63.
November 6, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2025 Abacus G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization)
September 25, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2025 Abacus UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization
September 25, 2025	EX-99.1	Abacus Shareholder Letter Abacus Shareholder Letter Setting Our Future Trajectory September 25, 2025 Dear Shareholders, Last month, we delivered another excellent quarter nearly doubling year-over-year revenue and adjusted net income.
August 26, 2025	15-12G	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-39403 Abacus Global Management, Inc. (Exact name of registrant as specif
August 14, 2025	EX-99.25	EX-99.25 abllw-form25
August 12, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001
August 12, 2025	EX-21.1	Subsidiaries of the Company Abacus Global Management, Inc. Subsidiaries of Registrant The following is a list of Abacus Global Management, Inc. subsidiaries, excluding insignificant subsidiaries in the aggregate. Subsidiaries State or Other Jurisdiction of Incorporation or Organization Longevity Market Assets, LLC Entity also does business under the name: •ABL Tech •ABL Technologies Delaware Abacus Settlements, LLC Entity al
August 8, 2025	EX-99.1	Abacus Global Management Reports Second Quarter 2025 Results August 7, 2025 8:15 PM EDT - Second Quarter 2025 Total Revenue Nearly Doubles Year-over-Year to $56.2 Million - - Longevity Funds Attracted $123.1 Million in Capital Inflows - - GAAP Net In ex991-ablq22025earningsr Abacus Global Management Reports Second Quarter 2025 Results August 7, 2025 8:15 PM EDT - Second Quarter 2025 Total Revenue Nearly Doubles Year-over-Year to $56.
August 8, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 Abacus Glo UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 00
July 31, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025 Abacus Glob UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001
July 31, 2025	EX-99.1	Abacus Global Management Announces Successful Completion of Exchange Offer and Consent Solicitation Exhibit 99.1 Abacus Global Management Announces Successful Completion of Exchange Offer and Consent Solicitation July 30, 2025 ORLANDO, Fla., July 30, 2025 (GLOBE NEWSWIRE) - Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today announced the completion of its previously announced exchange offer (the “Offer”) and consent
July 31, 2025	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025 Abacus Glob UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001
July 30, 2025	SC TO-I/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 2) Abacus Global Management, Inc. (Name of Subject Com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 2) Abacus Global Management, Inc. (Name of Subject Company and Filing Person (Issuer)) Warrants to Acquire Shares of Common Stock 00258Y112 (Title of Class of Securities) (CUSIP Number of
July 30, 2025	EX-10.1	AMENDMENT NO. 1 TO WARRANT AGREEMENT Exhibit 10.1 AMENDMENT NO. 1 TO WARRANT AGREEMENT This amendment (this “Amendment”) is made as of July 30, 2025, by and between Abacus Global Management, Inc. (f/k/a Abacus Life, Inc.), a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, as warrant agent (the “Warrant Agent”), and constitutes an amendment to that certain
July 30, 2025	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025 Abacus Glob UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001
July 30, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025 Abacus Glob UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001
July 30, 2025	EX-99.1	Abacus Global Management Announces Successful Warrant Exchange Offer Exhibit 99.1 Abacus Global Management Announces Successful Warrant Exchange Offer ORLANDO, Fla., July 30, 2025 (GLOBE NEWSWIRE) – Abacus Global Management, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a leader in the alternative asset management space, today announced the expiration and results of its previously announced exchange offer (the “Offer”) and consent solicitation (the “Consent Solic
July 29, 2025	424B3	Abacus Global Management, Inc. Offer to Exchange Warrants to Acquire Shares of Common Stock Abacus Global Management, Inc. Shares of Common Stock Abacus Global Management, Inc. Consent Solicitation TABLE OF CONTENTS Filed pursuant to Rule 424(b)(3) Registration No. 333-288412 Abacus Global Management, Inc. Offer to Exchange Warrants to Acquire Shares of Common Stock of Abacus Global Management, Inc. for Shares of Common Stock of Abacus Global Management, Inc. and Consent Solicitation THE OFFER PERIOD (AS DEFINED BELOW) AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., EASTERN TIME, ON JULY
July 15, 2025	EX-99.4	LETTER TO CLIENTS OF BROKERS, DEALERS, COMMERCIAL BANKS, TRUST COMPANIES, AND OTHER NOMINEES Offer to Exchange Warrants to Acquire Shares of Common Stock Abacus Global Management, Inc. Shares of Common Stock Abacus Global Management, Inc. Consent Sol Exhibit 99.4 LETTER TO CLIENTS OF BROKERS, DEALERS, COMMERCIAL BANKS, TRUST COMPANIES, AND OTHER NOMINEES Offer to Exchange Warrants to Acquire Shares of Common Stock of Abacus Global Management, Inc. for Shares of Common Stock of Abacus Global Management, Inc. and Consent Solicitation THE OFFER AND CONSENT SOLICITATION (EACH AS DEFINED BELOW) AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., EAS
July 15, 2025	CORRESP	* * * 811 Main Street, Suite 3700 Houston, TX 77002 Tel: +1.713.546.5400 Fax: +1.713.546.5401 www.lw.com FIRM / AFFILIATE OFFICES Austin Milan Beijing Munich Boston New York Brussels Orange County Century City Paris Chicago Riyadh July 15, 2025 Dubai San Diego Düsseldorf San Francisco Frankfurt Seoul Hamburg Silicon Valley Hong Kong Singapore Houston Tel Aviv London Tokyo Los Angeles Washington, D.C. Ma
July 15, 2025	SC TO-I/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1) Abacus Global Management, Inc. (Name of Subject Com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1) Abacus Global Management, Inc. (Name of Subject Company and Filing Person (Issuer)) Warrants to Acquire Shares of Common Stock 00258Y112 (Title of Class of Securities) (CUSIP Number of
July 15, 2025	EX-99.3	LETTER TO BROKERS, DEALERS, COMMERCIAL BANKS, TRUST COMPANIES, AND OTHER NOMINEES Offer to Exchange Warrants to Acquire Shares of Common Stock Abacus Global Management, Inc. Shares of Common Stock Abacus Global Management, Inc. Consent Solicitation Exhibit 99.3 LETTER TO BROKERS, DEALERS, COMMERCIAL BANKS, TRUST COMPANIES, AND OTHER NOMINEES Offer to Exchange Warrants to Acquire Shares of Common Stock of Abacus Global Management, Inc. for Shares of Common Stock of Abacus Global Management, Inc. and Consent Solicitation THE OFFER AND CONSENT SOLICITATION (EACH AS DEFINED BELOW) AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., EASTERN TIME,
July 15, 2025	S-4/A	As filed with the U.S. Securities and Exchange Commission on July 15, 2025. TABLE OF CONTENTS As filed with the U.S. Securities and Exchange Commission on July 15, 2025. Registration No. 333-288412 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware 6282
July 15, 2025	EX-10.23	Dealer Manager Agreement Exhibit 10.23 Dealer Manager Agreement July 15, 2025 SG Americas Securities, LLC 245 Park Avenue New York, New York 10167 Ladies and Gentlemen: Abacus Global Management, Inc., a corporation organized under the laws of Delaware (the “Company” or “we”), has initiated an exchange offer (together with any amendments, supplements or extensions thereof, the “Exchange Offer”) to exchange the Company’s ou
July 15, 2025	EX-99.1	LETTER OF TRANSMITTAL AND CONSENT Offer to Exchange Warrants to Acquire Shares of Common Stock Abacus Global Management, Inc. Shares of Common Stock Abacus Global Management, Inc. Consent Solicitation Exhibit 99.1 LETTER OF TRANSMITTAL AND CONSENT Offer to Exchange Warrants to Acquire Shares of Common Stock of Abacus Global Management, Inc. for Shares of Common Stock of Abacus Global Management, Inc. and Consent Solicitation THE OFFER AND CONSENT SOLICITATION (EACH AS DEFINED BELOW) AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., EASTERN TIME, ON JULY 29, 2025, OR SUCH LATER TIME AND DATE TO
July 9, 2025	LETTER	LETTER July 9, 2025 Jay J. Jackson Chief Executive Officer Abacus Global Management, Inc. 2101 Park Center Drive, Suite 200 Orlando, Florida 32835 Re: Abacus Global Management, Inc. Schedule TO-I Filed June 30, 2025 File No. 005-91592 Dear Jay J. Jackson: We have reviewed your filing and have the following comments. Please respond to these comments by providing the requested information or advise us as s
June 30, 2025	EX-99.1	Form of Letter of Transmittal and Consent. Exhibit 99.1 LETTER OF TRANSMITTAL AND CONSENT Offer to Exchange Warrants to Acquire Shares of Common Stock of Abacus Global Management, Inc. for Shares of Common Stock of Abacus Global Management, Inc. and Consent Solicitation THE OFFER AND CONSENT SOLICITATION (EACH AS DEFINED BELOW) AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., EASTERN TIME, ON JULY 29, 2025, OR SUCH LATER TIME AND DATE TO W
June 30, 2025	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001
June 30, 2025	EX-FILING FEES	Filing Fee Table. Exhibit 107 Calculation of Filing Fee Table Form S-4 (Form Type) Abacus Global Management, Inc.
June 30, 2025	EX-99.3	Form of Letter to Brokers, Dealers, Commercial Banks, Trust Companies, and Other Nominees. Exhibit 99.3 LETTER TO BROKERS, DEALERS, COMMERCIAL BANKS, TRUST COMPANIES, AND OTHER NOMINEES Offer to Exchange Warrants to Acquire Shares of Common Stock of Abacus Global Management, Inc. for Shares of Common Stock of Abacus Global Management, Inc. and Consent Solicitation THE OFFER AND CONSENT SOLICITATION (EACH AS DEFINED BELOW) AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., EASTERN TIME, ON
June 30, 2025	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2025 Abacus Glob UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001
June 30, 2025	EX-99.1	Abacus Global Management Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants Abacus Global Management Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants June 30, 2025 ORLANDO, Fla.
June 30, 2025	EX-99.2	Form of Notice of Guaranteed Delivery. Exhibit 99.2 NOTICE OF GUARANTEED DELIVERY OF WARRANTS OF ABACUS GLOBAL MANAGEMENT, INC Pursuant to the Prospectus/Offer to Exchange dated June 30, 2025 Instructions for Use Unless defined herein, terms used in this notice of guaranteed delivery (this “Notice of Guaranteed Delivery”) shall have the definitions set forth in the prospectus/offer to exchange, dated June 30, 2025 (as amended or supple
June 30, 2025	EX-99.4	Form of Letter to Clients of Brokers, Dealers, Commercial Banks, Trust Companies, and Other Nominees. Exhibit 99.4 LETTER TO CLIENTS OF BROKERS, DEALERS, COMMERCIAL BANKS, TRUST COMPANIES, AND OTHER NOMINEES Offer to Exchange Warrants to Acquire Shares of Common Stock of Abacus Global Management, Inc. for Shares of Common Stock of Abacus Global Management, Inc. and Consent Solicitation THE OFFER AND CONSENT SOLICITATION (EACH AS DEFINED BELOW) AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M., EASTE
June 30, 2025	SC TO-I	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Abacus Global Management, Inc. (Name of Subject Company and Filing Pe UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Abacus Global Management, Inc. (Name of Subject Company and Filing Person (Issuer)) Warrants to Acquire Shares of Common Stock (Title of Class of Securities) 00258Y112 (CUSIP Number of Class of Securities) Jay J. Jackso
June 30, 2025	S-4	As filed with the U.S. Securities and Exchange Commission on June 30, 2025. As filed with the U.S. Securities and Exchange Commission on June 30, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware 6282 85-1210472 (State or other jurisdiction of incorporation or organ
June 30, 2025	EX-10.1	Form of Tender and Support Agreement by and among the Company and the warrant holders party thereto. TENDER AND SUPPORT AGREEMENT This TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of June , 2025, is entered into by and among Abacus Global Management, Inc.
June 30, 2025	EX-FILING FEES	Filing Fee Table. Exhibit 107 Calculation of Filing Fee Table SC TO-I (Form Type) Abacus Global Management, Inc.
June 30, 2025	EX-99.1	Abacus Global Management Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants Abacus Global Management Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants June 30, 2025 ORLANDO, Fla.
June 27, 2025	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2025 Abacus Glob UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001
June 27, 2025	EX-99.1	Abacus Global Management Announces Intention to Conduct Exchange Offer and Consent Solicitation Relating to Warrants Abacus Global Management Announces Intention to Conduct Exchange Offer and Consent Solicitation Relating to Warrants June 27, 2025 ORLANDO, Fla.
June 27, 2025	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001
June 27, 2025	EX-99.1	Abacus Global Management Announces Intention to Conduct Exchange Offer and Consent Solicitation Relating to Warrants Abacus Global Management Announces Intention to Conduct Exchange Offer and Consent Solicitation Relating to Warrants June 27, 2025 ORLANDO, Fla.
June 13, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2025 Abacus Glob UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001
June 5, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2025 Abacus Globa UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-
May 12, 2025	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-3
May 8, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-3
May 8, 2025	EX-99.1	ABACUS GLOBAL MANAGEMENT REPORTS FIRST QUARTER 2025 RESULTS - First Quarter 2025 Total Revenue More Than Doubled Year-over-Year to $44.1 Million - - Longevity Funds Attracted $122.8 Million in Capital Inflows - - GAAP Net Income of $4.6 Million - - A ABACUS GLOBAL MANAGEMENT REPORTS FIRST QUARTER 2025 RESULTS - First Quarter 2025 Total Revenue More Than Doubled Year-over-Year to $44.
May 8, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00
April 28, 2025	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confi
April 28, 2025	ARS	ARS 2024 Annual ReportAbacus Global Management \| 2024 Annual Stockholder Letter Dear Valued Shareholders, As we reflect on an exciting year, we are thrilled to share some of the key milestones that have defined Abacus Global Management's (previously Abacus Life) continued growth and evolution throughout 2024.
April 28, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(
April 10, 2025	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 00
April 2, 2025	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 00
March 31, 2025	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 00
March 28, 2025	EX-4.11	Exhibit 4.11 ABACUS LIFE, INC. DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED The following is a description of the common stock, public warrants and 9.875% Fixed Rate Senior Notes due 2028 of Abacus Global Management, Inc. (the “Company,” “we,” “our,” or “us”), which are the only securities of the Company registered pursuant to Section 12 of the
March 28, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-394
March 28, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 00
March 28, 2025	EX-10.21	Form of Abacus Option Agreement 2024 Plan ABACUS LIFE, INC. STOCK OPTION AWARD AGREEMENT (ABACUS LIFE, INC. AMENDED AND RESTATED 2024 LONG-TERM EQUITY COMPENSATION INCENTIVE PLAN) THIS STOCK OPTION AWARD AGREEMENT, (this “Agreement”), dated as of [ ] (the “Date of Grant”), is made by and between Abacus Life, Inc., a Delaware corporation (the “Company”), and [ ] (the “Grantee” or “you” or “your”). WHEREAS, Grantee is employed by the Compan
March 28, 2025	EX-19.1	Insider Trading Policy ABACUS GLOBAL MANAGEMENT, INC. INSIDER TRADING POLICY Purpose This Insider Trading Policy (“Policy”) provides guidelines with respect to transactions in the securities of Abacus Global Managemnt, Inc.(together with its subsidiaries, “Abacus”) and the handling of confidential information about Abacus and the companies with which Abacus does business. Persons Subject to the Policy All directors, off
March 28, 2025	EX-21.1	Subsidiaries of the Company Abacus Global Management, Inc. Subsidiaries Subsidiaries State of Incorporation or Organization Longevity Market Assets, LLC Entity also does business under the name: •ABL Tech •ABL Technologies Delaware Abacus Settlements, LLC Entity also does business under the name: •Abacus Life Delaware ABL Technologies, LLC Florida Longevity Market Admin, LLC Florida Longevity Market Advisors, LLC Delaware Re
March 28, 2025	EX-99.1	ABACUS GLOBAL MANAGEMENT REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS - Delivered Record Full Year Revenue and Growth While Executing on Strategic Acquisitions and Initiatives - - Fourth Quarter 2024 Total Revenue Grows 40% Year-over-Year to $33 ABACUS GLOBAL MANAGEMENT REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS - Delivered Record Full Year Revenue and Growth While Executing on Strategic Acquisitions and Initiatives - - Fourth Quarter 2024 Total Revenue Grows 40% Year-over-Year to $33.
March 28, 2025	EX-10.22	Form of Abacus RSU Agreement 2024 Plan ABACUS LIFE, INC. RESTRICTED STOCK UNIT AWARD AGREEMENT (ABACUS LIFE, INC. AMENDED AND RESTATED 2024 LONG-TERM EQUITY COMPENSATION PLAN ) THIS RESTRICTED STOCK UNIT AWARD AGREEMENT, (this “Agreement”), dated as of [ ] (the “Date of Grant”), is made by and between Abacus Life, Inc., a Delaware corporation (the “Company”), and [ ] (the “Grantee” or “you” or “your”). WHEREAS, Grantee is employed by t
March 28, 2025	EX-3.3	Amended and Restated Bylaws of Abacus Global Management, Inc., dated February 27, 2025 AMENDED AND RESTATED BYLAWS OF ABACUS GLOBAL MANAGEMENT, INC. (THE “CORPORATION”) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as the Corporation’s registered a
March 24, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2025 Abacus Glo UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 00
March 24, 2025	EX-3.1	, incorporated by reference from the Company’s Form 8-K filed Abacus Global Management, Inc. Certificate of Designations Series A Convertible Preferred Stock March 17, 2025 Table of Contents Page Section 1. Definitions 1 Section 2. Rules of Construction 10 Section 3. The Convertible Preferred Stock 11 (a) Designation; Par Value 11 (b) Number of Authorized Shares 11 (c) Form, Dating and Denominations 11 (d) Method of Payment; Delay When Payment Date is Not a
March 5, 2025	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2025 Abacus Global Management, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization)
March 5, 2025	EX-3.1	Delaware The First State Page 1 7983570 8100 Authentication: 203072727 SR# 20250810203 Date: 03-04-25 You may verify this certificate online at corp.delaware.gov/authver.shtml I, CHARUNI PATIBANDA-SANCHEZ, SECRETARY OF STATE OF THE STATE OF DELAWARE, exhibit31-amendedcertifi Delaware The First State Page 1 7983570 8100 Authentication: 203072727 SR# 20250810203 Date: 03-04-25 You may verify this certificate online at corp.
February 4, 2025	424B3	9,213,735 Shares of Common Stock $72,727,075 Aggregate Principal Amount of 9.875% Fixed Rate Senior Notes due 2028 Filed Pursuant to Rule 424(b)(3) Registration No. 333-284325 PROSPECTUS 9,213,735 Shares of Common Stock $72,727,075 Aggregate Principal Amount of 9.875% Fixed Rate Senior Notes due 2028 This prospectus relates to the resale or other disposition from time to time of up to (i) 9,213,735 shares (the “Shares”) of common stock, par value $0.0001 per share (the “Common Stock”) and (ii) $72,727,075 aggr
January 31, 2025	CORRESP	Abacus Life, Inc. 2101 Park Center Drive, Suite 200 Orlando, Florida 32835 January 31, 2025 Abacus Life, Inc. 2101 Park Center Drive, Suite 200 Orlando, Florida 32835 January 31, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Attention: Aisha Adegbuyi Re: Abacus Life, Inc. Registration Statement on Form S-3 File No. 333-284325 Ladies and Gentlemen: In accordance with Rule 461 of Regulation C o
January 29, 2025	LETTER	LETTER January 29, 2025 Jay J. Jackson Chief Executive Officer Abacus Life, Inc. 2101 Park Center Drive, Suite 200 Orlando, Florida 32835 Re: Abacus Life, Inc. Registration Statement on Form S-3 Filed January 16, 2025 File No. 333-284325 Dear Jay J. Jackson: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding request
January 16, 2025	EX-FILING FEES	Filing Fee Table. Exhibit 107 Calculation of Filing Fee Tables FORM S-3 (Form Type) ABACUS LIFE, INC.
January 16, 2025	S-3	As filed with the Securities and Exchange Commission on January 16, 2025 As filed with the Securities and Exchange Commission on January 16, 2025 Registration No.
January 16, 2025	EX-25.1	Form T-1 Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of U.S. Bank Trust Company, National Association with respect to the Base Indenture referenced in Exhibit 4.1. Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) £ U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 91-1821036 I.R.S. E
December 16, 2024	EX-10.1	Form of Restricted Stock Unit Award granted under the Abacus Life, Inc. Amended and Restated 2024 Long-Term Equity Incentive Plan. ABACUS LIFE, INC. RESTRICTED STOCK UNIT AWARD AGREEMENT (ABACUS LIFE, INC. AMENDED AND RESTATED 2024 LONG-TERM EQUITY COMPENSATION PLAN ) THIS RESTRICTED STOCK UNIT AWARD AGREEMENT, (this “Agreement”), dated as of [ ] (the “Date of Grant”), is made by and between Abacus Life, Inc., a Delaware corporation (the “Company”), and [ ] (the “Grantee” or “you” or “your”). WHEREAS, Grantee is employed by t
December 16, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (C
December 10, 2024	SC 13D	ERES / Abacus Life Inc - Class A / Pillo Portsmouth Holding Company, LLC - SCHEDULE 13D Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Abacus Life, Inc. (Name of Issuer) Common Stock - $0.0001 par value per share (Title of Class of Securities) 274681105 (CUSIP Number) Pillo Portsmouth Holding Company, LLC 1658 N. Milwaukee Avenue, Suite 334 Chicago, Illinois 60647 Telephone: c/o +325-268-4-53-59 Copy
December 10, 2024	EX-10.2	Security Agreement, dated as of December 10, 2024, by and among the Grantors party thereto and GLAS USA LLC as Collateral Agent, incorporated by reference from the Company’s Form 8-K filed December 10, 2024. Execution Version SECURITY AGREEMENT dated December 10, 2024 among The Grantors referred to herein, as Grantors and GLAS USA LLC, as Collateral Agent Schedules: Schedule I - Location, Chief Executive Office, Jurisdiction of Organization, Organizational Identification Number, Tax Identification Number, Prior Names, etc.
December 10, 2024	EX-10.3	Guaranty, dated as of December 10, 2024 among Abacus Life, Inc. the Guarantors party thereto, and GLAS USA LLC as Administrative Agent, incorporated by reference from the Company’s Form 8-K filed December 10, 2024. Execution Version GUARANTY Dated as of December 10, 2024 among ABACUS LIFE, INC. THE OTHER GUARANTORS NAMED HEREIN and EACH ADDITIONAL GUARANTOR THAT BECOMES A PARTY HERETO, as Guarantors, and GLAS USA LLC, as Administrative Agent #4919-0286-4389v3 TABLE OF CONTENTS Section Page The table of contents is empty. Heading styles must be applied in the document and be selected in the table of contents
December 10, 2024	EX-99.1	Abacus Life Closes $150 Million Debt Financing Facility to Support Continued Growth Abacus Life Closes $150 Million Debt Financing Facility to Support Continued Growth ORLANDO, Fla.
December 10, 2024	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 10, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (C
December 10, 2024	EX-10.1	Credit Agreement, dated as of December 10, 2024, by and among Abacus Life, Inc. as the Borrower, GLAS USA LLC, as the Administrative Agent, GLAS AMERICAS LLC, as the Collateral Agent and the Lenders from time to time party thereto, incorporated by reference from the Company’s Form 8-K filed December 10, 2024. Execution Version CREDIT AGREEMENT Dated as of December 10, 2024 among Abacus Life, Inc.
December 10, 2024	EX-1	Joint Filing Agreement, dated as of December 2, 2024 Exhibit 1 JOINT FILING AGREEMENT Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the “Exchange Act”) the undersigned hereby agree to the joint filing on behalf of each of them of any filing required by such party under Section 13 of the Exchange Act or any rule or regulation thereunder (including any amendment, restatement, supplement, and/or exhibit thereto) with respect to securities of Abacus Life, Inc.
December 2, 2024	EX-99.1	Abacus Life Completes Acquisition of Carlisle Management Company S.C.A. Abacus Life Completes Acquisition of Carlisle Management Company S.C.A. ORLANDO, Fla., December 2, 2024 (GLOBE NEWSWIRE) - Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, today announced it has completed the acquisition of Car
December 2, 2024	EX-4.3	Second Supplemental Indenture, dated as of December 2, 2024, between the Company and U.S. Bank Trust Company, National Association, as Trustee, including the form of the New Notes (incorporated by reference to the Company’s current report on Form 8-K filed on December 2, 2024 as Exhibit 4.3). SECOND SUPPLEMENTAL INDENTURE between ABACUS LIFE, INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee Dated as of December 2, 2024 THIS SECOND SUPPLEMENTAL INDENTURE (this “Second Supplemental Indenture”), dated as of December 2, 2024, is between Abacus Life, Inc., a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).
December 2, 2024	EX-10.1	Share Lock-Up and Standstill Agreement, dated as of December 2, 2024, by and among the Company and the Stockholders party thereto (incorporated by reference to the Company’s current report on Form 8-K filed on December 2, 2024 as Exhibit 10.1). SHARE LOCK-UP AND STANDSTILL AGREEMENT This Share Lock-Up and Standstill Agreement (as amended, restated, supplemented or otherwise modified in accordance with Section 8.
December 2, 2024	EX-10.3	Equity Registration Rights Agreement, dated as of December 2, 2024, by and among the Company and the Holders of the common stock of the Company named therein (incorporated by reference to Exhibit 10.3 of the Company’s Form 8-K filed with the SEC on December 2, 2024). EQUITY REGISTRATION RIGHTS AGREEMENT THIS EQUITY REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of December 2, 2024, is made and entered into by and among Abacus Life, Inc.
December 2, 2024	EX-99.1	Abacus Life Completes Acquisition of FCF Advisors Abacus Life Completes Acquisition of FCF Advisors ORLANDO, Fla., December 2, 2024 (GLOBE NEWSWIRE) - Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, today announced it has completed the acquisition of FCF Advisors (“FCF”), a N
December 2, 2024	EX-10.2	Notes Registration Rights Agreement, dated as of December 2, 2024, by and among the Company and holders of the notes named therein (incorporated by reference to Exhibit 10.2 of the Company’s Form 8-K filed with the SEC on December 2, 2024). NOTES REGISTRATION RIGHTS AGREEMENT THIS NOTES REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of December 2, 2024, is made and entered into by and among Abacus Life, Inc.
December 2, 2024	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Co
December 2, 2024	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Co
November 25, 2024	EX-99.1	Abacus Life Announces Exhibit 99.1 Abacus Life Announces Pricing of Public Offering of Common Stock November 21, 2024 ORLANDO, November 21, 2024-(GLOBE NEWS WIRE) — Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the pricing of its underwritten public offering of 12,500,000 shares of its common stock,
November 25, 2024	424B2	Prospectus Supplement to Prospectus dated October 21, 2024 10,000,000 Shares of Common Stock Filed Pursuant to Rule 424(b)(2) Registration No. 333-282747 Prospectus Supplement to Prospectus dated October 21, 2024 10,000,000 Shares of Common Stock Abacus Life, Inc. (“Abacus,” “we,” “our,” “us” and the “Company) is offering 10,000,000 shares of the Company’s common stock, par value $0.0001 (the “Common Stock”). You should read this prospectus supplement and any other prospectus supplement o
November 25, 2024	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39403 85-1210472 (State or other jurisdiction of incorporation) (Commission Fil
November 25, 2024	424B7	Prospectus Supplement to Prospectus dated October 21, 2024 2,500,000 Shares of Common Stock Filed Pursuant to Rule 424(b)(7) Registration No. 333-273411 Prospectus Supplement to Prospectus dated October 21, 2024 2,500,000 Shares of Common Stock The selling securityholders identified in this prospectus supplement (the “Selling Securityholders”) are offering 2,500,000 shares of our common stock, par value $0.0001 per share (the “Common Stock”). You should read this prospectus supplement an
November 25, 2024	EX-99.2	Abacus Life Announces Exhibit 99.2 Abacus Life Announces Closing of Public Offering of 12,500,000 Shares of Common Stock November 25, 2024 ORLANDO, Fla., November 25, 2024 (GLOBE NEWSWIRE) – Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the closing of its oversubscribed underwritten public offering
November 25, 2024	EX-1.1	Underwriting Agreement, dated November 21, 2024, by and among Abacus Life, Inc., the Selling Stockholders and Piper Sandler & Co., TD Securities (USA) LLC, KKR Capital Markets LLC, B. Riley Securities, Inc. and SG Americas Securities, LLC, as Representatives of the several Underwriters named in Schedule I thereto. Exhibit 1.1 12,500,000 Shares ABACUS LIFE, INC. Common Stock UNDERWRITING AGREEMENT November 21, 2024 Piper Sandler & Co. TD Securities (USA) LLC KKR Capital Markets LLC B. Riley Securities, Inc. SG Americas Securities, LLC As Representatives of the several Underwriters named in Schedule I hereto c/o Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 c/o TD Securit
November 22, 2024	EX-99.1	Abacus Life Announces Exhibit 99.1 Abacus Life Announces Proposed Public Offering of Common Stock November 21, 2024 ORLANDO, Fla., November 21, 2024 (GLOBE NEWSWIRE) - Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in leveraging longevity and actuarial technology to offer uncorrelated investment opportunities, today announced the commencement of an under
November 22, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2024 Abacus Life, In UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39403 85-1210472 (State or other jurisdiction of incorporation) (Commission Fil
November 21, 2024	424B7	SUBJECT TO COMPLETION DATED , 2024 Prospectus Supplement to Prospectus dated October 21, 2024 2,500,000 Shares of Common Stock The information in this preliminary prospectus supplement is not complete and may be changed.
November 21, 2024	424B2	SUBJECT TO COMPLETION DATED , 2024 Prospectus Supplement to Prospectus dated October 21, 2024 10,000,000 Shares of Common Stock The information in this preliminary prospectus supplement is not complete and may be changed.
November 13, 2024	CORRESP	ABACUS LIFE, INC. 2101 Park Center Drive, Suite 200 Orlando, Florida 32835 ABACUS LIFE, INC. 2101 Park Center Drive, Suite 200 Orlando, Florida 32835 VIA EDGAR November 13, 2024 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Madeleine Joy Mateo Christian Windsor Re: Abacus Life, Inc. Registration Statement on Form S-3 Filed October 21, 2024 File No. 333-282747 Ladies and Gentlemen: Pursuant
November 7, 2024	LETTER	LETTER November 6, 2024 Jay J. Jackson President and CEO Abacus Life, Inc. 2101 Park Center Drive, Suite 200 Orlando, FL 32835 Re: Abacus Life, Inc. Post-Effective Amendment No. 1 to Registration Statement on Form S-1 on Form S-3 Filed October 21, 2024 Response Letter Dated November 4, 2024 File Number 333-273411 Dear Jay J. Jackson: We have reviewed your response letter dated November 4, 2024 and have t
November 7, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Co
November 7, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe
November 7, 2024	CORRESP	* * * November 7, 2024 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.
November 7, 2024	EX-21.1	Subsidiaries of the Company Abacus Life, Inc. Subsidiaries Subsidiaries State of Incorporation or Organization Longevity Market Assets, LLC Entity also does business under the name: •ABL Tech •ABL Technologies Delaware Abacus Settlements, LLC Entity also does business under the name: •Abacus Life Delaware ABL Technologies, LLC Florida Longevity Market Admin, LLC Florida Longevity Market Advisors, LLC Delaware Regional Invest
November 7, 2024	EX-99.1	ABACUS LIFE REPORTS THIRD QUARTER 2024 RESULTS - Delivered Continued Revenue and Profitability Growth While Executing on Strategic Initiatives - - Third Quarter 2024 Total Revenue Grows 33% Year-over-Year to $28.1 Million - - Due to Non-Cash Increase ABACUS LIFE REPORTS THIRD QUARTER 2024 RESULTS - Delivered Continued Revenue and Profitability Growth While Executing on Strategic Initiatives - - Third Quarter 2024 Total Revenue Grows 33% Year-over-Year to $28.
November 7, 2024	CORRESP	* * * November 7, 2024 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.
November 6, 2024	LETTER	LETTER November 6, 2024 Jay J. Jackson President and CEO Abacus Life, Inc. 2101 Park Center Drive, Suite 200 Orlando, FL 32835 Re: Abacus Life, Inc. Registration Statement on Form S-3 Filed October 21, 2024 Response Letter Submitted November 4, 2024 File No. 333-282747 Dear Jay J. Jackson: We have reviewed your response letter received November 4, 2024 and have the following comments. Please respond to t
November 4, 2024	CORRESP	* * * November 4, 2024 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.
November 4, 2024	CORRESP	* * * November 4, 2024 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.
November 1, 2024	LETTER	LETTER November 1, 2024 Jay J. Jackson President and CEO Abacus Life, Inc. 2101 Park Center Drive, Suite 200 Orlando, FL 32835 Re: Abacus Life, Inc. Post-Effective Amendment No. 1 to Registration Statement on Form S-1 on Form S-3 Filed October 21, 2024 File No. 333-273411 Dear Jay J. Jackson: We have conducted a limited review of your registration statement and have the following comments. Please respond
November 1, 2024	LETTER	LETTER November 1, 2024 Jay J. Jackson President and CEO Abacus Life, Inc. 2101 Park Center Drive, Suite 200 Orlando, FL 32835 Re: Abacus Life, Inc. Registration Statement on Form S-3 Filed October 21, 2024 File No. 333-282747 Dear Jay J. Jackson: We have conducted a limited review of your registration statement and have the following comments. Please respond to this letter by amending your registration
October 22, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 22, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Co
October 22, 2024	EX-99.1	ABACUS LIFE PROVIDES PRELIMINARY THIRD QUARTER 2024 RESULTS - Expects Total Revenue Between $26.0 and $28.0 Million; Grows 23-33% Year-over-Year - - Expects GAAP Net Income / (Loss) Between ($6.0) and ($6.75) Million Due to Non-Cash Increase in Warra ABACUS LIFE PROVIDES PRELIMINARY THIRD QUARTER 2024 RESULTS - Expects Total Revenue Between $26.
October 21, 2024	S-3	As filed with the Securities and Exchange Commission on October 21, 2024 As filed with the Securities and Exchange Commission on October 21, 2024 Registration No.
October 21, 2024	EX-FILING FEES	), filed with the SEC on EX-FILING FEES 2 exhibit107-posam.htm EX-FILING FEES Exhibit 107 Calculation of Filing Fee Table Form S-1 (Form Type) Abacus Life, Inc. (Exact Name of Registrant as Specified in its Charter) Newly Registered and Carry Forward Shares Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price
October 21, 2024	POS AM	As filed with the Securities and Exchange Commission on October 21, 2024 As filed with the Securities and Exchange Commission on October 21, 2024 Registration No.
October 21, 2024	EX-FILING FEES	Filing Fee Table Exhibit 107 Calculation of Filing Fee Table Registration Statement on Form S-3 (Form Type) Abacus Life, Inc.
August 12, 2024	EX-99.1	ABACUS LIFE REPORTS SECOND QUARTER 2024 RESULTS - Second Quarter 2024 Total Revenue More Than Doubled Year-over-Year to $29.1 Million - - Net Income of $0.8 Million; Adjusted Net Income Grows 75% Year-over-Year to $11.8 Million - - Adjusted EBITDA Gr ABACUS LIFE REPORTS SECOND QUARTER 2024 RESULTS - Second Quarter 2024 Total Revenue More Than Doubled Year-over-Year to $29.
August 12, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Com
August 12, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001
August 7, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Comm
August 7, 2024	EX-99.1	Abacus Life Announces Agreement to Acquire FCF Advisors Acquisition accelerates expansion of ABL Wealth with a diverse suite of products Deal will add up to $600 million in AUM to Abacus Abacus Life Announces Agreement to Acquire FCF Advisors Acquisition accelerates expansion of ABL Wealth with a diverse suite of products Deal will add up to $600 million in AUM to Abacus ORLANDO, Fla.
August 7, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Comm
July 18, 2024	EX-99.1	ABACUS LIFE PROVIDES PRELIMINARY SECOND QUARTER 2024 RESULTS - Expects Total Revenue Between $28.0 and $30.0 Million; Grows 146-163% Year-over-Year - - Expects Net Income Between $0.0 and $1.0 Million - - Expects Adjusted EBITDA Between $15.0 and $17 ABACUS LIFE PROVIDES PRELIMINARY SECOND QUARTER 2024 RESULTS - Expects Total Revenue Between $28.
July 18, 2024	EX-99.1	Abacus Life Announces Agreement to Acquire Carlisle Management Company SCA Acquisition accelerates Abacus' expansion as a global alternative asset manager and origination company Deal will add up to $2 billion in AUM to Abacus Abacus Life Announces Agreement to Acquire Carlisle Management Company SCA Acquisition accelerates Abacus' expansion as a global alternative asset manager and origination company Deal will add up to $2 billion in AUM to Abacus ORLANDO, Fla.
July 18, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 18, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Commi
July 18, 2024	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 18, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Commi
July 18, 2024	EX-2.1	Share Purchase Agreement, by and among Abacus Life, Inc., Carlisle Management Company S.C.A., Carlisle Investment Group S.A.R.L., the Sellers party thereto, Jose Eseteban Casares Garcia, Manorhaven Holdings, LLC, Pacific Current Group Limited, certain equityholders of CMC Vehicle, LLC and Pillo Portsmouth Holding Company, LLC, in its capacity as the Sellers’ Representative thereunder, dated as of July 18, 2024 (incorporated by reference to the Company’s current report on Form 8-K filed on July 18, 2024 as Exhibit 2.1). SHARE PURCHASE AGREEMENT BY AND AMONG ABACUS LIFE, INC., CARLISLE MANAGEMENT COMPANY S.C.A., CARLISLE INVESTMENT GROUP S. À R.L., THE SELLERS PARTY HERETO, JOSE ESTEBAN CASARES GARCIA, (solely with respect to Section 4.8, Section 6.11, Section 6.12, Section 6.18, Section 6.20, Section 9.4(c), and Section 9.4(d)), MANORHAVEN HOLDINGS, LLC, (solely with respect to Section 6.11 and Section 6.12) PACI
June 28, 2024	EX-FILING FEES	Filing Fee Table Calculation of Filing Fee Table Form S-8 (Form Type) Abacus Life, Inc. (Exact Name of Registrant as Specified in its Charter) Newly Registered and Carry Forward Shares Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fee
June 28, 2024	S-8	As filed with the Securities and Exchange Commission on June 28, 2024. As filed with the Securities and Exchange Commission on June 28, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 6282 85-1210472 (State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. E
June 24, 2024	EX-99.2	Abacus Life Announces Closing of Public Offering of 11,500,000 Shares of Common Stock Exhibit 99.2 Abacus Life Announces Closing of Public Offering of 11,500,000 Shares of Common Stock June 24, 2024 ORLANDO, Fla., June 24, 2024 (GLOBE NEWSWIRE) – Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the closing of its oversubscribed underwritten public offering of 11,50
June 24, 2024	EX-1.1	Underwriting Agreement, dated June 20, 2024, by and between Abacus Life, Inc. and Piper Sandler & Co., TD Securities (USA) LLC, B. Riley Securities, Inc. and KKR Capital Markets LLC, as Representatives of the several Underwriters named in Schedule I thereto Exhibit 1.1 10,000,000 Shares ABACUS LIFE, INC. Common Stock UNDERWRITING AGREEMENT June 20, 2024 Piper Sandler & Co. TD Securities (USA) LLC B. Riley Securities, Inc. KKR Capital Markets LLC As Representatives of the several Underwriters named in Schedule I hereto c/o Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 c/o TD Securities (USA) LLC 1 Vanderbilt Avenu
June 24, 2024	EX-99.1	Abacus Life Announces Pricing of Public Offering of Common Stock Exhibit 99.1 Abacus Life Announces Pricing of Public Offering of Common Stock June 20, 2024 ORLANDO, June 20, 2024-(GLOBE NEWS WIRE) — Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the pricing of its oversubscribed underwritten public offering of 10,000,000 shares of its common
June 24, 2024	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39403 85-1210472 (State or other jurisdiction of incorporation) (Commission File Nu
June 21, 2024	424B1	10,000,000 Shares Common Stock Filed Pursuant to Rule 424(b)(1) Registration No. 333-279347 Prospectus 10,000,000 Shares Common Stock This is an offering of common stock by Abacus Life, Inc. (the “Company”). We are offering 10,000,000 shares of the Company’s common stock. You should read this prospectus and any prospectus supplement or amendment carefully before you invest in our securities. Our common stock is listed on The Na
June 17, 2024	CORRESP	[Signature Page Follows] VIA EDGAR Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 TD Securities (USA) LLC 1 Vanderbilt Avenue New York, New York 10017 B. Riley Securities, Inc. 1300 17th Street North, Suite 1300 Arlington, Virginia 22209 KKR Capital Markets LLC 30 Hudson Yards, 75th Floor New York, New York 10001 June 17, 2024 Securities and Exchange Commission Division of Corporation
June 17, 2024	CORRESP	ABACUS LIFE, INC. 2101 Park Center Drive, Suite 170 Orlando, Florida 32835 ABACUS LIFE, INC. 2101 Park Center Drive, Suite 170 Orlando, Florida 32835 VIA EDGAR June 17, 2024 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Aisha Adegbuyi Christian Windsor Re: Abacus Life, Inc. Registration Statement on Form S-1 Filed May 10, 2024 File No. 333-279347 Ladies and Gentlemen: Pursuant to Rule 461
June 14, 2024	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Commi
June 13, 2024	S-1/A	As filed with the Securities and Exchange Commission on June 13, 2024. As filed with the Securities and Exchange Commission on June 13, 2024. Registration No. 333-279347 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 6282 85-1210472 (State or Other Jurisdiction of Incorporation o
June 13, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39403 85-1210472 (State or other jurisdiction of incorporation) (Commission File Nu
June 13, 2024	EX-99.1	Abacus Life Announces Proposed Public Offering of Common Stock Exhibit 99.1 Abacus Life Announces Proposed Public Offering of Common Stock June 13, 2024 ORLANDO, Fla., June 13, 2024 (GLOBE NEWSWIRE) - Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock
June 13, 2024	EX-1.1	Form of Underwriting Agreement. Exhibit 1.1 [ ò ] Shares ABACUS LIFE, INC. Common Stock UNDERWRITING AGREEMENT [ ò ], 2024 Piper Sandler & Co. TD Securities (USA) LLC B. Riley Securities, Inc. KKR Capital Markets LLC As Representatives of the several Underwriters named in Schedule I hereto c/o Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 c/o TD Securities (USA) LLC 1 Vanderbilt Avenue New Y
June 13, 2024	EX-FILING FEES	Filing Fee Table Exhibit 107 Calculation of Filing Fee Table Registration Statement on Form S-1 (Form Type) Abacus Life, Inc.
June 12, 2024	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 2) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 2) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-3
May 31, 2024	S-1/A	As filed with the Securities and Exchange Commission on May 30, 2024. As filed with the Securities and Exchange Commission on May 30, 2024. Registration No. 333-279347 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 6282 85-1210472 (State or Other Jurisdiction of Incorporation or
May 31, 2024	EX-1.1	Form of Underwriting Agreement. Exhibit 1.1 [l] Shares ABACUS LIFE, INC. Common Stock UNDERWRITING AGREEMENT [l], 2024 Piper Sandler & Co. TD Securities (USA) LLC KKR Capital Markets LLC As Representatives of the several Underwriters named in Schedule I hereto c/o Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 c/o TD Securities (USA) LLC 1 Vanderbilt Avenue New York, New York 10017 c/o KKR Ca
May 30, 2024	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission
May 30, 2024	CORRESP	* * * 811 Main Street, Suite 3700 Houston, TX 77002 Tel: +1.713.546.5400 Fax: +1.713.546.5401 www.lw.com FIRM / AFFILIATE OFFICES Austin Milan Beijing Munich Boston New York Brussels Orange County Century City Paris Chicago Riyadh Dubai San Diego Düsseldorf San Francisco Frankfurt Seoul Hamburg Silicon Valley Hong Kong Singapore Houston Tel Aviv London Tokyo Los Angeles Washington, D.C. Madrid May 30, 2
May 21, 2024	LETTER	LETTER United States securities and exchange commission logo May 21, 2024 Jay J. Jackson Chief Executive Officer Abacus Life, Inc. 2101 Park Center Drive, Suite 170 Orlando, Florida 32835 Re: Abacus Life, Inc. Registration Statement on Form S-1 Filed May 10, 2024 File No. 333-279347 Dear Jay J. Jackson: We have conducted a limited review of your registration statement and have the following comments. Ple
May 13, 2024	EX-99.1	1 ABACUS LIFE REPORTS FIRST QUARTER 2024 RESULTS - First Quarter 2024 Total Revenue More Than Doubled Year-over-Year to $21.5 Million - - Driven by 59% Year-over-Year Growth in Direct-to-Consumer Division - ORLANDO, Fla. – May 13, 2024 – Abacus Life, 1 ABACUS LIFE REPORTS FIRST QUARTER 2024 RESULTS - First Quarter 2024 Total Revenue More Than Doubled Year-over-Year to $21.
May 13, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2024 Abacus Life, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Commis
May 13, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00
May 10, 2024	S-1	As filed with the Securities and Exchange Commission on May 10, 2024. As filed with the Securities and Exchange Commission on May 10, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 6282 85-1210472 (State or Other Jurisdiction of Incorporation or Organization) (Primary S
May 10, 2024	EX-FILING FEES	Filing Fee Table Exhibit 107 Calculation of Filing Fee Table Registration Statement on Form S-1 (Form Type) Abacus Life, Inc.
April 29, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1
April 29, 2024	ARS	ARS 2023 Annual ReportAbacus Life - 2023 Annual Stockholder Letter Dear Valued Stockholders: 2023 was a transformative year for Abacus Life.
April 29, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confi
April 29, 2024	DEFA14A	DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1
April 26, 2024	DRS	As confidentially submitted with the Securities and Exchange Commission on April 26, 2024. As confidentially submitted with the Securities and Exchange Commission on April 26, 2024.
March 21, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-394
March 21, 2024	EX-4.14	Description of registrant’s securities 2023. ABACUS LIFE, INC. DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED The following is a description of the common stock of Abacus Life, Inc. (the “Company,” “we,” “our,” or “us”), which is the only security of the Company registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The followi
March 21, 2024	EX-99.1	ABACUS LIFE REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS - Fourth Quarter 2023 Total Revenue Grew 25% Year-over-Year to $23.6 Million - - Increased Originations Capital Deployment by 92% Year-over-Year to $68.3 Million - - Increased Originations ABACUS LIFE REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS - Fourth Quarter 2023 Total Revenue Grew 25% Year-over-Year to $23.
March 21, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Comm
March 21, 2024	EX-97.1	Clawback policy. ABACUS LIFE, INC CLAWBACK POLICY Policy Statement It is the policy of Abacus Life, Inc.
February 15, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (C
February 15, 2024	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Co
February 15, 2024	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (C
February 15, 2024	EX-1.1	Underwriting Agreement, dated February 9, 2024, by and between the Company and Piper Sandler & Co. and each of the other underwriters named in Exhibit A thereto. Execution Version ABACUS LIFE, INC. $25,000,000 9.875% Fixed Rate Senior Notes due 2028 UNDERWRITING AGREEMENT February 9, 2024 Piper Sandler & Co., As representative of the several Underwriters c/o Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 Ladies and Gentlemen: Abacus Life, Inc., a Delaware corporation (the “Company”), confirms its agreements with Piper S
February 13, 2024	424B3	9.875% Fixed Rate Senior Notes due 2028 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-276795 PROSPECTUS $25,000,000 9.875% Fixed Rate Senior Notes due 2028 Abacus Life, Inc., a Delaware corporation (“Abacus” or the “Company”), is offering an additional $25,000,000 aggregate principal amount (the “notes”) of its 9.875% Fixed Rate Senior Notes due 2028 that are listed on the Nasdaq Global Market® (“NASDAQ”) under
February 13, 2024	SC 13G/A	US00258Y1047 / ABACUS LIFE INC / SZOP MULTISTRAT LP Passive Investment SC 13G/A 1 formsc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Abacus Life, Inc. (f/k/a East Resources Acquisition Co) (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 00258Y104 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Stat
February 12, 2024	SC 13G/A	US00258Y1047 / ABACUS LIFE INC / Alberta Investment Management Corp - SC 13G/A Passive Investment SC 13G/A 1 d744854dsc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) ABACUS LIFE, INC. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 00258Y104 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appro
February 9, 2024	S-1/A	As filed with the Securities and Exchange Commission on February 9 , 2024. Table of Contents As filed with the Securities and Exchange Commission on February 9 , 2024.
February 9, 2024	EX-1.1	Form of Underwriting Agreement. Exhibit 1.1 ABACUS LIFE, INC. $15,000,000 9.875% Fixed Rate Senior Notes due 2028 UNDERWRITING AGREEMENT February 9, 2024 Piper Sandler & Co., As representative of the several Underwriters c/o Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 Ladies and Gentlemen: Abacus Life, Inc., a Delaware corporation (the “Company”), confirms its agreements with Piper Sandler
February 7, 2024	LETTER	LETTER United States securities and exchange commission logo February 7, 2024 Jay J. Jackson Chief Executive Officer Abacus Life, Inc. 2101 Park Center Drive, Suite 170 Orlando, FL 32835 Re: Abacus Life, Inc. Registration Statement on Form S-1 Filed January 31, 2024 File No. 333-276795 Dear Jay J. Jackson: This is to advise you that we have not reviewed and will not review your registration statement. Pl
February 7, 2024	CORRESP	[Signature Page Follows] VIA EDGAR Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 February 7, 2024 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: John Stickel Re: Abacus Life, Inc. Registration Statement on Form S-1 File No. 333-276795 Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933
February 7, 2024	CORRESP	February 7, 2024 February 7, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Finance 100 F Street NE Washington, D.
January 31, 2024	S-1	As filed with the Securities and Exchange Commission on January 31, 2024. Table of Contents As filed with the Securities and Exchange Commission on January 31, 2024.
January 31, 2024	EX-FILING FEES	Filing Fee Table Exhibit 107 Calculation of Filing Fee Table Form S-1 (Form Type) Abacus Life, Inc.
January 9, 2024	EX-99.1	Abacus Life Repurchases $1.9 Million of Stock in First 30 Days of Program January 9, 2024 1:00 PM EST ORLANDO, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a leading buyer of life insurance poli a991-abacusliferepurchas Abacus Life Repurchases $1.9 Million of Stock in First 30 Days of Program January 9, 2024 1:00 PM EST ORLANDO, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) - Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, provided an update to i
January 9, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2024 Abacus Li UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2024 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (Com
December 29, 2023	EX-10.3	Letter Agreement, dated as of December 20, 2023, among the Company, East Sponsor, LLC and Lifebridge Holdings, LLC, incorporated by reference from the Company’s Form 8-K filed December 29, 2023. a103-abacusxxletterxagr 135715511v.2 ABACUS LIFE, INC. 2101 Park Center Drive, Suite 170 Orlando, Florida 32835 December 20, 2023 Lifebridge Holdings, LLC 2101 Park Center Drive, Suite 170 Orlando, Florida 32835 East Sponsor, LLC 7777 NW Beacon Square Boulevard Boca Raton, Florida 33487 Re: Private Warrant Standstill Ladies and Gentlemen: Reference is made to the warrants to purchase shares of com
December 29, 2023	EX-10.1	Amendment No. 1 to the Sponsor Support Agreement, dated as of December 20, 2023, by and among Abacus Life, Inc., Longevity Market Assets, LLC, Abacus Settlements, LLC and East Sponsor, LLC, incorporated by reference from the Company’s Form 8-K filed December 29, 2023. a101-amendment1xtoxspon AMENDMENT NO. 1 to SPONSOR SUPPORT AGREEMENT This Amendment No. 1 to the Sponsor Support Agreement (this “Amendment”), is entered into as of December 20, 2023, by and among Abacus Life, Inc., a Delaware corporation formerly known as East Resources Acquisition Company (“Abacus Life”), Longevity Market Assets, LLC (“LMA”), Abacus Settlements, LLC (“Abacus Settlements”), and E
December 29, 2023	EX-10.2	Amendment No. 1 to the Company Support Agreement, dated as of December 20, 2023, by and among Abacus Life, Inc., Longevity Market Assets, LLC, Abacus Settlements, LLC, T. Sean McNealy, K. Scott Kirby, Matthew A, incorporated by reference from the Company’s Form 8-K filed December 29, 2023. a102-amendment1xtoxcomp AMENDMENT NO. 1 to COMPANY SUPPORT AGREEMENT This Amendment No. 1 to the Company Support Agreement (this “Amendment”), is entered into as of December 20, 2023, by and among Abacus Life, Inc., a Delaware corporation formerly known as East Resources Acquisition Company (“Abacus Life”), Longevity Market Assets, LLC (“LMA”), Abacus Settlements, LLC (“Abacus Settlements”), each
December 29, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2023 Abacus UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2023 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (C
December 12, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 11, 2023 Abacus UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 11, 2023 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (C
December 12, 2023	EX-99.1	Abacus Life Announces $15 Million Stock Repurchase Program Abacus Life Announces $15 Million Stock Repurchase Program Orlando, Fla. – December 11, 2023 – Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, announced today that its Board of Directors has authorized a new stock repurchase program of up to $15
November 21, 2023	CERT	CERT The Nasdaq Stock Market LLC, 805 King Farm Blvd., Rockville, MD 20850 Eun Ah Choi Senior Vice President U.S. Listing Qualifications & Market Surveillance November 21, 2023 Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Division of Corporation Finance: This is to certify that on November 20, 2023, The Nasdaq Stock Market LLC (the "E
November 20, 2023	8-A12B	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Abacus Life, Inc. (Exact Name of Registrant as Specified U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 85-1210472 (State of Incorporation or Organization) (I.R.S. Employer Identification No.) 2101 Park Center Drive, Suite 170 O
November 20, 2023	EX-99.1	3Q 2023 IMPORTANT NOTE TO INVESTORS: On or about November 14, 2023 a document titled “Abacus Life Q3 Board Presentation November 9, 2023” (the “Disclaimed Document”) entered the public domain. The Company advises investors not to rely upon the Discla 3Q 2023 IMPORTANT NOTE TO INVESTORS: On or about November 14, 2023 a document titled “Abacus Life Q3 Board Presentation November 9, 2023” (the “Disclaimed Document”) entered the public domain.
November 20, 2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2023 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (C
November 13, 2023	EX-4.2	Supplemental Indenture, incorporated by reference from the Company’s Form 8-K filed November 13, 2023. Exhibit 4.2 FIRST SUPPLEMENTAL INDENTURE between ABACUS LIFE, INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee Dated as of November 10, 2023 THIS FIRST SUPPLEMENTAL INDENTURE (this “First Supplemental Indenture”), dated as of November 10, 2023, is between Abacus Life, Inc., a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the
November 13, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe
November 13, 2023	EX-99.1	ABACUS LIFE REPORTS THIRD QUARTER 2023 RESULTS - Total Revenue Grew 20% Year-over-Year to $21.1 Million - - Increased Originations Capital Deployment by 43% Year-over-Year to $51 Million - - GAAP Net Income of $0.9 Million; non-GAAP Adjusted Net Inco ABACUS LIFE REPORTS THIRD QUARTER 2023 RESULTS - Total Revenue Grew 20% Year-over-Year to $21.
November 13, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2023 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-39403 (C
November 13, 2023	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2023 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39403 85-1210472 (State or other jurisdiction of incorporation or organ
November 13, 2023	EX-4.1	Base Indenture, incorporated by reference from the Company’s Form 8-K filed November 13, 2023. Exhibit 4.1 ABACUS LIFE, INC., ISSUER AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, TRUSTEE SENIOR DEBT SECURITIES INDENTURE Dated as of November 10, 2023 TABLE OF CONTENTS Page ARTICLE I Definitions and Other Provisions of General Application 1 Section 1.1 Definitions 1 Section 1.2 Compliance Certificates and Opinions 6 Section 1.3 Form of Documents Delivered to Trustee 7 Section 1.4 Acts of
November 6, 2023	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2023 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39403 85-1210472 (State or other jurisdiction of incorporation or organi
November 6, 2023	424B3	9.875% Fixed Rate Senior Notes due 2028 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-274553 PROSPECTUS $31,000,000 9.875% Fixed Rate Senior Notes due 2028 Abacus Life, Inc., a Delaware corporation (“Abacus” or the “Company”), is offering $31,000,000 aggregate principal amount of Fixed Rate Senior Notes (the “notes”). The notes will bear interest at the rate of 9.875% per annum, payable quarterly in arrears on
November 6, 2023	EX-1.1	Underwriting Agreement, dated November 2, 2023, by and between the Company and Piper Sandler & Co., as representative of the several Underwriters named in Exhibit A thereto. Exhibit 1.1 ABACUS LIFE, INC. $31,000,000 9.875% Fixed Rate Senior Notes due 2028 UNDERWRITING AGREEMENT November 2, 2023 Piper Sandler & Co., As representative of the several Underwriters c/o Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 Ladies and Gentlemen: Abacus Life, Inc., a Delaware corporation (the “Company”), confirms its agreements with Piper Sandler
November 1, 2023	S-1/A	As filed with the Securities and Exchange Commission on November 1, 2023. Registration No. 333-274553 U N ITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT No. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES AC Table of Contents As filed with the Securities and Exchange Commission on November 1, 2023.
October 31, 2023	CORRESP	October 31, 2023 October 31, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Finance 100 F Street NE Washington, D.
October 31, 2023	CORRESP	[Signature Page Follows] VIA EDGAR Piper Sandler & Co. 1251 Avenue of the Americas, 6th Floor New York, New York 10020 October 31, 2023 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Aisha Adegbuyi and Christian Windsor Re: Abacus Life, Inc. Registration Statement on Form S-1 File No. 333-274553 Ladies and Gentlemen: In accordance with Rule 461 under the

ERES / Abacus Life Inc - Class A - SEC-arkivering, Årsberetning, Fuldmagtserklæring

Grundlæggende statistik

SEC Filings

SEC Filings (Chronological Order)

How Much do you Like Fintel?

Write a Review and get 25% Off Your Next Purchase

How can we Improve?